ISOPP has been invited to collaborate in the creation of the Handbook, which as a first step, will commence with generation of an initial set of 4 of these Treatment Regimens. What WHO is asking for from ISOPP is to provide feedback from the point of view of an Oncology Pharmacist on the feasibility/practicality/challenges and pitfalls of implementing and delivering these chemotherapy regimens in the Low and Middle Income Country (LMIC) context.